Predicting and detecting seizures: can digital health technologies help clinicians up their game?

Three specialists discuss how new technologies could soon be utilized in the field of seizure prediction and detection to improve patient care.

Prof. Brinkmann has disclosed that he is/was a consultant/advisor for Otsuka Pharmaceuticals Co., Ltd., that he is/was a research/grant recipient from the Epilepsy Foundation of America, and that he owns royalties/patents for Cadence Neuroscience Inc.

Prof. Cook has disclosed that he owns royalties/patents/stocks for Epi-Minder Pty. Ltd. and Seer Medical Pty. Ltd., and that he has an employment affiliation with Epi-Minder Pty. Ltd. and Seer Medical Pty. Ltd.

Prof. Rubboli has disclosed that he is/was on a speaker’s bureau for Arvelle Therapeutics International Gmbh, Biocodex S.A., Eisai Co., Ltd. and UCB (Union Chimique Belge) and that he is/was a consultant/advisor for Arvelle Therapeutics International Gmbh, Biocodex S.A., Eisai Co., Ltd. and UCB (Union Chimique Belge).